 |
|
Tumor DNA Content in Primary and Metastatic Colorectal Carcinoma
William A. Kokal, MD;
Rosemary B. Duda, MD;
Norio Azumi, MD;
Khalil Sheibani, MD;
M. Margaret Kemeny, MD;
Jose J. Terz, MD;
J. Richard Harada
Arch Surg. 1986;121(12):1434-1439.
Abstract
| |
• We performed this study to determine if tumor DNA content was an independent prognostic indicator in patients with primary tumors or hepatic metastases from colorectal cancer. We analyzed tumor DNA content by flow cytometry from paraffin-embedded specimens in 133 patients. In the 77 patients with primary colorectal cancer who had had "curative" resection, DNA content of the tumor was an independent prognostic indicator in predicting both relapse-free and overall survival. Logistics regression analysis demonstrated that aneuploidy, ie, tumors that exhibited a population of cells with an "abnormal" DNA content, was the single most important variable in predicting both recurrence and death from disease, even more important than stage. However, in 56 patients with hepatic metastases from colorectal cancer, the DNA content of the liver metastases bore no relationship to the patients' survival or their response to therapy. These data suggest that tumor DNA content is an important prognostic indicator in patients with primary colorectal carcinoma but does not reflect the natural history of patients with liver metastases.
(Arch Surg 1986;121:1434-1439)
Author Affiliations
From the Department of General Oncologic Surgery (Drs Kokal, Duda, Kemeny, and Terz and Mr Harada) and the Division of Anatomic Pathology (Drs Azumi and Sheibani), City of Hope National Medical Center, Duarte, Calif.
Footnotes
Accepted for publication Aug 13, 1986.
Read before the 39th Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 14, 1986.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
